Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Essen Biotech
M.D. Anderson Cancer Center
City of Hope Medical Center
Curacell Holding AB
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Valo Therapeutics Oy
TCR2 Therapeutics
University of Pittsburgh